ArticleVaccine: X2020

Immunogenicity and safety of concurrent or sequential administration of live, attenuated SA 14-14-2 Japanese encephalitis vaccine (CD-JEV) and measles-mumps-rubella vaccine in infants 9-12 months of age in the Philippines: A non-inferiority Phase 4 randomized clinical trial.

Maria Rosario Capeding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.